Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Pediatr Crit Care Med. 2017 Oct;18(10):e446–e454. doi: 10.1097/PCC.0000000000001280

Figure 3.

Figure 3

Expected AKIN stage in relation to number of epinephrine doses received for subjects with and without abnormal baseline creatinine. The likelihood of No AKI decreases while likelihood of AKIN Stages 1–3 increases with increasing number of epinephrine doses. This effect is reliably influenced by baseline creatinine, favoring more AKI when baseline creatinine is abnormal. Expected AKIN Stage 3 accelerates in likelihood after 8–9 epinephrine doses. The effect of having an abnormal versus normal baseline creatinine on likelihood of AKIN Stages 1 and 2 appears attenuated after 8–9 epinephrine doses.